- Home
- NOG vs VKTX Comparison
NOG vs VKTX Comparison
Compare NOG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOG
- VKTX
- Stock Information
- Founded
- NOG 2006
- VKTX 2012
- Country
- NOG United States
- VKTX United States
- Employees
- NOG N/A
- VKTX N/A
- Industry
- NOG Oil & Gas Production
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- NOG Energy
- VKTX Health Care
- Exchange
- NOG Nasdaq
- VKTX Nasdaq
- Market Cap
- NOG 3.6B
- VKTX 3.4B
- IPO Year
- NOG N/A
- VKTX 2015
- Fundamental
- Price
- NOG $30.20
- VKTX $24.15
- Analyst Decision
- NOG Buy
- VKTX Strong Buy
- Analyst Count
- NOG 8
- VKTX 11
- Target Price
- NOG $45.50
- VKTX $95.18
- AVG Volume (30 Days)
- NOG 1.8M
- VKTX 3.8M
- Earning Date
- NOG 04-29-2025
- VKTX 04-23-2025
- Dividend Yield
- NOG 5.60%
- VKTX N/A
- EPS Growth
- NOG N/A
- VKTX N/A
- EPS
- NOG 5.14
- VKTX N/A
- Revenue
- NOG $2,006,670,000.00
- VKTX N/A
- Revenue This Year
- NOG $14.42
- VKTX N/A
- Revenue Next Year
- NOG $9.15
- VKTX N/A
- P/E Ratio
- NOG $5.88
- VKTX N/A
- Revenue Growth
- NOG 14.87
- VKTX N/A
- 52 Week Low
- NOG $26.60
- VKTX $23.27
- 52 Week High
- NOG $44.31
- VKTX $82.00
- Technical
- Relative Strength Index (RSI)
- NOG 44.72
- VKTX 33.93
- Support Level
- NOG $29.75
- VKTX $25.80
- Resistance Level
- NOG $31.59
- VKTX $29.60
- Average True Range (ATR)
- NOG 0.87
- VKTX 1.61
- MACD
- NOG 0.38
- VKTX -0.30
- Stochastic Oscillator
- NOG 62.73
- VKTX 10.72
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. Company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), and the Appalachian Basin (Pennsylvania and Ohio).
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.